Εσθονία - Εσθονικά - Ravimiamet

vitabalans oy - tsitalopraam - õhukese polümeerikattega tablett - 20mg 30tk; 20mg 60tk; 20mg 20tk; 20mg 10tk

Εσθονία - Εσθονικά - Ravimiamet

vitabalans oy - tsitalopraam - õhukese polümeerikattega tablett - 40mg 60tk; 40mg 30tk; 40mg 10tk; 40mg 14tk; 40mg 100tk

Εσθονία - Εσθονικά - Ravimiamet

boehringer ingelheim international gmbh - olodaterool - inhalatsioonilahus - 2,5mcg 1mõõtannus 60mõõtannus 2tk; 2,5mcg 1mõõtannus 60mõõtannus 8tk; 2,5mcg 1mõõtannus 60mõõtannus 1tk

Εσθονία - Εσθονικά - Ravimiamet

teva pharma b.v. - flupirtiin - kõvakapsel - 100mg 10tk; 100mg 30tk

Εσθονία - Εσθονικά - Ravimiamet

merck sharp & dohme oÜ - risatriptaan - tablett - 5mg 3tk; 5mg 2tk; 5mg 12tk; 5mg 18tk

Εσθονία - Εσθονικά - Ravimiamet

accord healthcare b.v. - estsitalopraam - õhukese polümeerikattega tablett - 10mg 14tk

Ευρωπαϊκή Ένωση - Εσθονικά - EMA (European Medicines Agency)

bayer ag - darolutamide - prostatic kasvajad, kastreerimine-vastupidavad - endokriinset ravi - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

Ευρωπαϊκή Ένωση - Εσθονικά - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - imipenem monohüdraat, cilastatin naatrium, relebactam monohüdraat - gram-negatiivne bakter-nakkused - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 ja 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 ja 5. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.

Ευρωπαϊκή Ένωση - Εσθονικά - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - muud antianemic preparaadid - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.

Ευρωπαϊκή Ένωση - Εσθονικά - EMA (European Medicines Agency)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - suguhormoonid ja immunoglobuliinid, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.